INFLUENTIAL RISK FACTORS IN THE DEVELOPMENT OF ENDOMETRIAL HYPERPLASIA DURING THE LATE REPRODUCTIVE PERIOD

Article Sidebar

PDF (English)
Выпуск: Том 4 № 8 : Естественные науки в современном мире: теоретические и практические исследования
Раздел: Статьи
Опубликован:

Main Article Content

Bukhara State Medical Institute named after Abu Ali ibn Sino, Uzbekistan, Bukhara, Gijduvanskiy st. 23,
info@bsmi.uz
Bukhara State Medical Institute named after Abu Ali ibn Sino, Uzbekistan, Bukhara, Gijduvanskiy st. 23,
info@bsmi.uz
Bukhara State Medical Institute named after Abu Ali ibn Sino, Uzbekistan, Bukhara, Gijduvanskiy st. 23,
info@bsmi.uz

Аннотация:

The aim of the study is to determine the risk factors for the development of hyperplastic complications in early reproductive age.

Article Details

Как цитировать:

Dustova , N., Kurbonova , G., & Kodirova, Z. (2025). INFLUENTIAL RISK FACTORS IN THE DEVELOPMENT OF ENDOMETRIAL HYPERPLASIA DURING THE LATE REPRODUCTIVE PERIOD. Естественные науки в современном мире: теоретические и практические исследования, 4(8), 68–75. извлечено от https://in-academy.uz/index.php/zdtf/article/view/56720

Библиографические ссылки:

Gromova A.L. Relationship between recurrent hyperplastic processes of the endometrium and genetic determinants Arg72Pro of the p53 gene and (ss) of the l-myc gene // Novgorod State University Bulletin. 2016. No. 1 (92).

Demakova N.A. Molecular genetic characteristics of patients with endometrial hyperplasia and polyps // Scientific results of biomedical research. 2018. No. 2.

Lapina I.A., Dobrokhotova Yu.E., Ozolinya L.A., Chirvon T.G., Taranov V.V. An integrated approach to the management of patients with endometrial hyperplasia and metabolic syndrome // Gynecology. 2021. No. 1.

Nazirova Z.M. Modern possibilities of diagnostics of proliferative processes of the endometrium // Economy and society. 2020. No. 4 (71).

Orazov M.R., Mikhaleva L.M., Mullina I.A. Prediction of recurrent endometrial hyperplasia // Difficult patient. 2021. No. 7.

Orazov M.R., Mikhaleva L.M., Mullina I.A., Leffad L.M. Pathogenesis of recurrent endometrial hyperplasia without atypia // Difficult patient. 2021. No. 6.

Ponomarenko I.V., Demakova N.A., Altukhova O.B. Molecular mechanisms of development of hyperplastic processes of the endometrium // Actual problems of medicine. 2016. No. 19 (240).

Saduakasova Sh. M., Argynbaev E. K., Shadenova E. E., Khaldarbekova E. N. Clinical effectiveness of hormonal therapy for endometrial hyperplasia // Bulletin of KazNMU. 2017. No. 1.

Sogikyan A.S., Idrisov Sh.T., Samsonova I.P. Efficiency of endometrial thermal ablation using the Thermachoice system in the treatment of metrorrhagia and endometrial hyperplastic processes (recurrent endometrial polyps) in peri- and menopause // Research'n Practical Medicine Journal. 2016. No. Special issue.

Tikhomirov A.L. Rationale for the use of combined oral contraceptives for the prevention of recurrence of typical endometrial hyperplasia // Gynecology. 2018. No. 4.

Tkachenko L.V., Sviridova N.I., Isaeva L.V. Prevention of recurrence of endometrial hyperplasia in perimenopause // Bulletin of VolSMU. 2017. No. 4 (64).

Filippova R.D., Neustroeva T.N., Pavlova-Afanasyeva M.P. Modern methods of treatment of hyperplastic processes of the endometrium (new technology) // Research'n Practical Medicine Journal. 2016. No. Special issue.

Chekhoeva A. N., Gabaraev G. M., Baroeva M. D. Clinical and diagnostic aspects and treatment tactics of endometrial hyperplastic processes from a modern perspective (literature review) // Bulletin of new medical technologies. Electronic publication. 2019. No. 4.

Shakirova E.A., Artymuk N.V. Risk factors for treatment failure and recurrent course of endometrial hyperplastic processes in women of reproductive age with obesity // Fundamental and Clinical Medicine. 2016. No. 1.

Shakirova E.A., Zotova O.A. The state of metabolic processes in women of reproductive age with obesity and hyperplastic processes of the endometrium // Fundamental and clinical medicine. 2016. No. 2.

Al-Kaabi M, Noel K, Al-Rubai AJ. Evaluation of immunohistochemical expression of stem cell markers (NANOG and CD133) in normal, hyperplastic, and malignant endometrium. J Med Life. 2022 Jan;15(1):117-123. doi: 10.25122/jml-2021-0206.

Begum J, Samal R. A Clinicopathological Evaluation of Postmenopausal Bleeding and Its Correlation with Risk Factors for Developing Endometrial Hyperplasia and Cancer: A Hospital-Based Prospective Study. J Midlife Health. 2019 Oct-Dec;10(4):179-183. doi: 10.4103/jmh.JMH_136_18.

Behrouzi R, Barr CE, Crosbie EJ. HE4 as a Biomarker for Endometrial Cancer. Cancers (Basel). 2021 Sep 23;13(19):4764. doi: 10.3390/cancers13194764.

Catena U, Della Corte L, Raffone A, Travaglino A, Lucci Cordisco E, Teodorico E, Masciullo V, Bifulco G, Di Spiezio Sardo A, Scambia G, Fanfani F. Fertility-sparing treatment for endometrial cancer and atypical endometrial hyperplasia in patients with Lynch Syndrome: Molecular diagnosis after immunohistochemistry of MMR proteins. Front Med (Lausanne). 2022 Aug 25;9:948509. doi: 10.3389/fmed.2022.948509.

Chae-Kim J, Garg G, Gavrilova-Jordan L, Blake LE, Kim TT, Wu Q, Hayslip CC. Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis. Int J Gynecol Cancer. 2021 Dec;31(12):1499-1505. doi: 10.1136/ijgc-2021-002699.

Chen J, Cao D, Yang J, Yu M, Zhou H, Cheng N, Wang J, Zhang Y, Peng P, Shen K. Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity. Front Oncol. 2022 Feb 18;12:812346. doi: 10.3389/fonc.2022.812346.

Chen J, Cheng Y, Fu W, Peng X, Sun X, Chen H, Chen X, Yu M. PPOS Protocol Effectively Improves the IVF Outcome Without Increasing the Recurrence Rate in Early Endometrioid Endometrial Cancer and Atypical Endometrial Hyperplasia Patients After Fertility Preserving Treatment . Front Med (Lausanne). 2021 Jul 27;8:581927. doi: 10.3389/fmed.2021.581927.